CollPlant Biotechnologies Ltd (CLGN) Executive Compensation
CollPlant Biotechnologies Ltd (CLGN) is a publicly traded company on the Nasdaq, categorized under SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CLGN
CIK: 1631487
Exchange: Nasdaq
SIC 3842: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kost Forer Gabbay & Kasierer
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerElad Sternlicht
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-15 | 2026-10-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-109552 | View SEC Doc Filr Page |
| 6-K | 2026-10-09 | 2026-10-09 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-108575 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-08 | — | SCHEDULE 13G Filing | 0001213900-26-107785 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-10-08 | — | SCHEDULE 13D/A Filing | 0001213900-26-107784 | View SEC Doc Filr Page |
| 6-K | 2026-10-06 | 2026-10-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-106988 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-105352 | View SEC Doc Filr Page |
| 6-K | 2026-09-24 | 2026-09-24 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-102965 | View SEC Doc Filr Page |
| 6-K | 2026-09-22 | 2026-09-22 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-102033 | View SEC Doc Filr Page |
| 6-K | 2026-09-18 | 2026-09-18 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-101147 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | OWNERSHIP DOCUMENT | 0001213900-26-098038 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | OWNERSHIP DOCUMENT | 0001213900-26-098037 | View SEC Doc Filr Page |
| 6-K | 2026-09-04 | 2026-09-04 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-097435 | View SEC Doc Filr Page |
| 6-K | 2026-09-03 | 2026-09-03 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-096971 | View SEC Doc Filr Page |
| 6-K | 2026-09-01 | 2026-09-01 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-096233 | View SEC Doc Filr Page |
| 6-K | 2026-08-31 | 2026-08-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-095458 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-21 | — | SCHEDULE 13D/A Filing | 0001104659-26-099668 | View SEC Doc Filr Page |
| 6-K | 2026-08-18 | 2026-08-18 | FORM 6-K | 0001213900-26-091292 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-08-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-086132 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-31 | — | SCHEDULE 13D/A Filing | 0001104659-26-089193 | View SEC Doc Filr Page |
| 6-K | 2026-07-29 | 2026-07-29 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-082528 | View SEC Doc Filr Page |
| 6-K | 2026-07-28 | 2026-07-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-082250 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-27 | — | SCHEDULE 13D/A Filing | 0001104659-26-087077 | View SEC Doc Filr Page |
| D | 2026-07-20 | — | D Filing | 0001213900-26-079611 | View SEC Doc Filr Page |
| 424B3 | 2026-07-17 | — | PROSPECTUS | 0001213900-26-078942 | View SEC Doc Filr Page |
| EFFECT | 2026-07-16 | — | EFFECT Filing | 9999999995-26-002340 | View SEC Doc Filr Page |